There are two types of nonrhegmatogenous RD: traction and exudative (serous). Traction RD occurs ... in the development of rhegmatogenous retinal detachment are retinal breaks and vitreous traction.

The Phase I/II LIGHTHOUSE trial is assessing the safety and tolerability of the gene therapy in male subjects.

The FDA granted fast track designation to ATSN-201 for the treatment of X-linked retinoschisis, according to a press release ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug ...

Central retinal artery occlusion (CRAO) is an ophthalmological emergency. Various treatment modalities have been tried, but none have shown to alter natural history of the disease. Hyperoxia can ...

Rights Mar 17, 2011 Mar 18, 2011 Jul 29, 2010 Rights ratio: 3 share for every 5 held at a price of Rs 103.0 ...

A concerning series of fatal attacks could lead to more breeds being restricted.

“We found the most magical furever home for her” - General Hospital alum Vanessa Marcil helps rehome a rescue dog ...